Inox India — funds quietly built it, now marked up
Inox India Ltd
Snapshot
Inox India makes cryogenic equipment — the big vacuum-insulated tanks and systems that store and move gases kept super-cold as liquids (LNG, liquid oxygen/nitrogen, and even rocket-fuel cryogenics for space and defence). It’s a clean, debt-free, high-return mid-cap riding India’s gas-infrastructure and energy-transition build-out. Market cap ₹18,080 Cr, CMP ₹1,988, 52-week range ₹1,065 – ₹2,099 — and price is sitting right near the top of that range (89% of the way up, just 5% off its high). Footprint headline: domestic funds have quietly accumulated a quality compounder, and the position is now being marked up.
As of 2026-06-24 — screener financials + Yahoo daily chart.
The verdict box
| Lens | Reading |
|---|---|
| Institutional ownership (FII+DII) | ▲ adding — combined ~11.1% → ~14.9% over 9 quarters; DII accelerating (6.7→7.7% last 3 q), FII plateaued near 7.1% |
| Volume footprint | Accumulation/Markup — up-vs-down volume 1.96, OBV rising in step with price (no divergence) |
| Wyckoff phase | Markup — 89% up its 52-week range, above a rising 50- & 200-DMA, golden cross, up-spikes on breakouts |
| Business quality gate | Institutional-grade compounder — ROE 26%, ROCE 33%, near debt-free, 22% profit CAGR (but P/E 69, P/B 16 — pricey) |
| Footprint verdict | Accumulating → Marking up (conviction: high on direction; the near-term leg is hot) |
The evidence says big professional money has been steadily building this position and is the kind of business it owns for the long run — but the price has just run hard, so the easy accumulation has happened and you’re buying into a fast markup.
In plain English
Inox India came to the market a couple of years ago, and since then two things have happened in its share register at the same time. First, the number of small shareholders has collapsed — from about 238,000 down to 140,000, a 41% drop. Second, the big professional investors have steadily added: foreign funds went from under 5% to about 7%, and Indian mutual funds and insurers from about 6.5% to nearly 8%. Put together, that’s the textbook fingerprint of accumulation — shares moving out of lots of small, weak hands and into a few large, patient ones, while the price climbed the whole way.
The chart and the volume agree with the register. On the days the stock went up, far more shares changed hands than on the days it went down (almost twice as much). And a running tally that adds volume on up-days and subtracts it on down-days (called OBV) is rising right alongside the price — meaning the buying is real, not a thin pump. There’s no warning sign here of the price being secretly propped up while insiders sell.
Where is the stock in its journey? It’s in the mark-up phase — the part where the position has already been built and the price is now being walked higher. It’s near its all-time high, above its rising average lines, and the recent up-days have been explosive (one day in early June saw the stock jump 12% on roughly six times the normal volume — 4 million shares). That kind of action is buyers stepping on the gas, not sellers sneaking out.
The business behind it is genuinely the sort funds want to own: it earns a high return on the money invested (around 26%), carries almost no debt, and has grown profits at roughly 22% a year for five years. The one real tension is price — at 69 times earnings and 16 times book value, it is expensive, and it has just run up about 40% in six weeks. So the accumulation story is sound and multi-quarter; what’s hot is the current leg.
Lens 1 — The ownership ledger (FII/DII)
| Quarter | Promoters | FIIs | DIIs | Public | No. of Shareholders |
|---|---|---|---|---|---|
| Dec 2023 | 75.0 | 4.65 | 6.48 | 13.87 | 237,966 |
| Mar 2024 | 75.0 | 6.14 | 6.58 | 12.28 | 189,674 |
| Sep 2024 | 75.0 | 5.84 | 7.14 | 12.02 | 179,293 |
| Mar 2025 | 75.0 | 6.85 | 6.26 | 11.90 | 183,577 |
| Sep 2025 | 75.0 | 7.12 | 6.70 | 11.16 | 168,589 |
| Dec 2025 | 75.0 | 7.14 | 7.27 | 10.57 | 149,132 |
| Mar 2026 | 75.0 | 7.13 | 7.72 | 10.14 | 140,355 |
Source: screener.in quarterly shareholding pattern. This is one of the cleaner accumulation ledgers you’ll see. Promoters held a rock-steady 75% the entire time — maximum alignment, no selling, no pledge flagged. FIIs built from ~4.7% to ~7.1% through 2024–25, then plateaued the last three quarters (7.12 → 7.14 → 7.13). DIIs are now the active buyer — flat-to-down through mid-2025, then a clear acceleration into the last two quarters (6.70 → 7.27 → 7.72). So there’s a mild handoff: foreigners did the early loading and have paused; domestic funds have picked up the baton. Meanwhile the public float keeps shrinking (13.9% → 10.1%) and the shareholder count has fallen 41% — the register is concentrating into fewer, bigger hands. Retail leaving + institutions adding + price rising = accumulation, not distribution.
Lens 2 — The tape (volume & delivery footprint)
The tape confirms the ledger. Over the last ~50 sessions, volume on up-days was nearly double volume on down-days (up/down ratio 1.96 — anything above 1.2 means buyers are in control). The OBV line (the running buy-minus-sell volume tally) is rising in step with price, with no divergence — so the climb is backed by genuine demand, not a hollow drift. The standout days lean heavily bullish: 9 up-spikes vs 6 down-spikes, and the biggest ones were buying into strength on breakouts — +6.6% on ~9× volume (Apr 10), +8.2% on ~13× (Apr 13), and the monster +12.1% on ~13× volume / 4 million shares (Jun 10). That’s mark-up behaviour (buying as price breaks higher), not the quiet absorption-at-the-lows you’d see in early accumulation. Today itself was quiet (volume 0.76× normal). Honesty note: Yahoo’s feed is total traded volume, not NSE delivery volume (shares actually taken into demat) — the best Indian accumulation tell. I didn’t pull delivery data here, so I’m anchoring the read on the filed FII/DII ledger above, which corroborates the tape strongly.
Lens 3 — The phase (Wyckoff structure)
Markup. Price sits at 89% of its 52-week range (just 5% off the high), comfortably above a rising 50-DMA (₹1,581) and 200-DMA (₹1,274) with a golden cross in place (the 50-day average above the 200-day) — the signature of a trend being marked up. The accumulation happened earlier (the long 2024–early-2026 stretch when the shareholder count collapsed and FII/DII rose); what we’re watching now is the price being walked higher on dominant up-volume. The 20-day range is wide (47%) precisely because the stock just ran ~40% — this is not a tight coiled-spring base, it’s an active advance. The discriminator at this height in the range is whether OBV still confirms (markup) or has started to diverge (distribution); here OBV is still rising with no divergence, so this reads as markup, not a top. The only caution the structure flags is extension — a hot, fast leg, not a stealthy one.
Lens 4 — The quality gate
Institutional-grade compounder. At ₹18,080 Cr it’s a liquid mid-cap any fund can own. Returns are excellent and consistent — ROE 26% (3-yr 28.7%, 5-yr 29%), ROCE 33.5% — the hallmark of a business that compounds capital well. Growth is durable: sales ₹650 Cr (FY19) → ₹1,587 Cr (FY26), profit up ~22% a year over five years, with steady ~22% operating margins. It’s almost debt-free (interest cost is trivial), so no leverage risk to amplify a downturn. The clear caveat is valuation: P/E ~69.5 and P/B ~16.2 — the one “con” screener flags. So institutional buying here is paying a full price for quality plus the gas-infra / cryogenics theme; it’s a quality-and-momentum bet, not a value one. That grade means: weight the accumulation signals as real and worth respecting, but recognise the cushion if sentiment turns is thin.
Where the lenses agree — and disagree
All four point the same way: a clean ledger (rising FII+DII, collapsing retail count, steady 75% promoter), a confirming tape (up/down volume 1.96, OBV rising), a markup phase, and an institutional-grade business. That’s a high-conviction direction. The two honest tensions: (1) the handoff — FII has plateaued for three quarters and DII is now doing the buying, so the next shareholding filing matters; if DII keeps adding and FII re-engages, the accumulation thesis strengthens; if both stall while price holds, watch for the first hint of distribution. (2) Valuation + extension — the business deserves owning, but the stock has run ~40% in six weeks to a rich multiple, so the easy accumulation is behind it; you’d be buying into a hot markup, not a quiet base. The single piece of data that settles the direction next is the June-2026 quarter shareholding pattern (does DII keep climbing past 7.7%?), backed by a delivery-volume check on the next pullback.
The watch-list
- DII stake — does it push above 7.72% next quarter (thesis intact) or stall (caution)?
- FII stake — does it break out of the ~7.1% plateau it’s held for three quarters? A re-engagement would be a fresh bullish leg.
- Up/down volume ratio — holds above 1.2 = buyers still in control; a drop below ~0.85 would flag distribution.
- OBV — keeps making new highs with price (healthy) vs starts to flatten/diverge while price holds (the distribution warning to fear at this range height).
- 50-DMA (~₹1,581) — on the inevitable pullback, does price hold above it (markup intact) or lose it (markup stalling)?
- Shareholder count — keeps falling (concentrating) vs starts climbing again (retail piling into strength — the late-stage tell).
Sources
- Screener: https://www.screener.in/company/INOXINDIA/consolidated/ — quarterly shareholding pattern (FII/DII), P&L, ratios.
- Chart: Yahoo Finance symbol INOXINDIA.NS (NSE), 291 daily bars through 2026-06-24.
- Volume is total traded volume, not NSE delivery volume — delivery-% was not separately sourced; the filed FII/DII ledger is the corroborating anchor.
- As of 2026-06-24.